Eris Lifesciences Limited Provides Earnings Guidance for the Fiscal 2025 and Fiscal 2026
For the fiscal 2026, the company has kind of a target of doing a revenue of around INR 26,000 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
896 INR | +0.27% | +1.63% | -1.54% |
1st Jan change | Capi. | |
---|---|---|
-1.54% | 1.46B | |
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |